Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01520025|
Recruitment Status : Terminated (Continued recruitment of study participants was not feasible)
First Posted : January 27, 2012
Last Update Posted : April 24, 2017
Ottawa Heart Institute Research Corporation
Information provided by (Responsible Party):
Terrence Ruddy, Ottawa Heart Institute Research Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Terminated|
|Actual Primary Completion Date :||January 2015|
|Actual Study Completion Date :||January 2015|
Abramson BL, Ruddy TD, deKemp RA, Laramee LA, Marquis JF, Beanlands RS. Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women. J Nucl Cardiol. 2000 May-Jun;7(3):205-12.
He ZX, Shi RF, Wu YJ, Tian YQ, Liu XJ, Wang SW, Shen R, Qin XW, Gao RL, Narula J, Jain D. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation. 2003 Sep 9;108(10):1208-13. Epub 2003 Aug 25.